HPI Software for Low Blood Pressure
Trial Summary
What is the purpose of this trial?
A prospective single-center randomized controlled trial to determine if guided hemodynamic management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of hypotension in cardiac surgery patients requiring cardiopulmonary bypass.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Acumen HPI Software Feature for low blood pressure?
The research highlights the potential of health information technology, like the Acumen HPI Software, to improve blood pressure management by providing clinical decision support and data visualization. Although the studies focus on hypertension (high blood pressure), the principles of using technology to monitor and manage blood pressure could be relevant for low blood pressure as well.12345
How does the Acumen HPI Software Feature treatment for low blood pressure differ from other treatments?
The Acumen HPI Software Feature is unique because it uses advanced software to assist in decision-making for managing low blood pressure, unlike traditional treatments that rely solely on medication. This software provides a personalized approach by analyzing patient data to optimize treatment strategies.56789
Eligibility Criteria
This trial is for adults who are scheduled for 'on-pump' heart surgery with an overnight hospital stay. They must be in a stable physical condition (ASA ≤ 4), have no severe low heart function or pulmonary hypertension, and not be part of another study. Emergency surgery patients or those needing a heart transplant are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Guided hemodynamic management with Acumen HPI technology in the OR and ICU
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Acumen HPI Software Feature
Find a Clinic Near You
Who Is Running the Clinical Trial?
Edwards Lifesciences
Lead Sponsor
Todd Brinton
Edwards Lifesciences
Chief Medical Officer since 2023
MD from Stanford University
Bernard Zovighian
Edwards Lifesciences
Chief Executive Officer since 2023
MBA from INSEAD